Page 8 - Company On Twitter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CNS Pharmaceuticals Announces Pricing of $4 0 Million Public Offering

CNS Pharmaceuticals Announces Pricing of $4 0 Million Public Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesJenene thomasMaxim groupExchange commissionCompany registration statement on formCompany on twitterPharmaceuticals incA gp alliance global partnersSecurities exchangeSeriesb warrantsAlliance global partnersSecurities actSecurities exchange actPrivate securities litigation reform actRegistration statement

CNS Pharmaceuticals, Inc : CNS Pharmaceuticals Announces Pricing of $4 0 Million Public Offering

CNS Pharmaceuticals, Inc : CNS Pharmaceuticals Announces Pricing of $4 0 Million Public Offering
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesNew yorkStefan klotterJenene thomasPharmaceuticals incSecurities exchangeExchange commissionCompany on twitterA gp alliance global partnersMaxim groupCompany registration statement on formSeriesb warrantsAlliance global partnersSecurities actSecurities exchange actPrivate securities litigation reform act

CNS Pharmaceuticals Announces Pricing of $4 0 Million Public Offering

CNS Pharmaceuticals Announces Pricing of $4 0 Million Public Offering
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMaxim groupCompany on twitterCompany registration statement on formTeam llcjenene thomasNews networkSecurities exchangeA gp alliance global partnersPharmaceuticals incExchange commissionSeriesb warrantsAlliance global partnersLooking statements someSecurities actSecurities exchange act

Autonomix Medical, Inc Announces Closing of $11 2 Million in Gross Proceeds from Initial Public Offering

26.01.2024 - Shares to begin trading on NASDAQ on January 29, 2024 under the ticker symbol “AMIX” THE WOODLANDS, TX., Jan. 26, 2024 (GLOBE NEWSWIRE) - Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on .

Jenene thomasAutonomix medical incExchange commissionCompany on twitterAutonomix medical

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

WALTHAM, Mass., Jan. 25, 2024 (GLOBE NEWSWIRE) OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals

New yorkUnited statesCathy klemaLynn oconnor vosAshley robinsonGus halasLynn vosCatherinem klemaDilma bennettAndy dsilvaBoard of managers quorum healthMedisafe incCompany on twitterBoard of trustees montefiore health systemCompany nasdaqFurman selz